An Alabama-based physician received a 16-month prison sentence for signing off on medically unnecessary genetic tests and durable medical equipment orders, resulting in millions in false Medicare claims.
As the 2026 ADA Standards of Care emphasize earlier identification and more precise classification of diabetes, clinical laboratories are rethinking workflows, assay menus, and their role in detection.
The VISQUE DPS LH210 supports up to 210 slides per batch and scans at 23 seconds per slide, expanding Vieworks' digital pathology lineup.
The Vizient Innovative Technology Program evaluates products submitted through client-led councils for their potential to improve clinical care, patient safety, and business operations.
The approval makes MyChoice CDx the sole FDA-approved test in the US to identify HRD-positive patients eligible for niraparib maintenance therapy.
